芙媄登Formaderm品牌怎么样 申请店铺

更新时间:2023-03-31
芙媄登Formaderm是哪个国家的品牌?「芙媄登Formaderm」是和康生物科技股份有限公司旗下著名品牌。该品牌发源于台湾,由创始人徐立德在1998期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
芙媄登Formaderm怎么样

和康生物科技股份有限公司(以下简称和康公司),于1998年12月成立于台北,次年进驻国立阳明大学设立育成中心,从事胶原蛋白研发工作。2002年6月由前财政部长创投法人徐立德主导的寰宇集团接手入股,以专业技术导向的高端医材、医美保养品为主,目前主要股东还包含那斯达克挂牌的医材大厂NuVasive、兆丰金控,第一金控…等。

和康以生物高分子、陶瓷材料核心技术,发展胶原蛋白萃取、胶原蛋白/生物陶瓷复合材料、可吸收麟酸钙陶瓷、透明质酸等,切入医材及医美领域。目前已获得台湾、美国、欧盟…等地合计超过27张许可证,涵盖骨科、眼科、牙科、皮肤愈伤、整形外科……等各大领域。近年来,和康公司更运用胶原蛋白与玻尿酸在生物医材研发的专业技术,开发出各具特色的自有品牌。

2009年获得美国FDA实地查厂认证,2012年和康公司与美国那斯达克挂牌上市公司ExactechInc.技术合作。2011年和康公司代工的屈臣氏保养品及面膜荣获屈臣氏健康美丽大赏多项“最佳商品”及“最佳新品”大奖。

另外要特别说明的和康公司董事长徐立德博士为前总统府资深政客,历任政府各项重要公职包括财政部长、经济部长、经建会主任委员、行政院副院长和总统府资政。徐先生拥有丰富的跨国公司经验,目前仍担任加拿大丰业银行及美国XL保险股份有限公司的咨询委员。曾任台湾科学学会理事长,获美国艾森豪威尔奖金。1985年获美国哈佛大学公共行政硕士,并于1996年获加拿大维多利亚大学荣誉法学博士。徐先生是环宇集团创办人兼董事长。环宇投资是台湾较早成立的投资公司,也是台湾较早且规模较大的创投之一。

Hekang Biotechnology Co., Ltd. (hereinafter referred to as Hekang company) was founded in Taipei in December 1998. The next year, it entered the national Yangming university to set up a training center and engaged in collagen research and development. In June 2002, Huanyu Group, led by Xu Lide, the former finance minister and venture capital legal person, took over and became a shareholder, mainly focusing on high-end medical materials and medical care products guided by professional technology. At present, the main shareholders include nuvasive, Zhaofeng financial holding and first financial holding, which are listed by Nasdaq And so on. With the core technology of biopolymer and ceramic materials, Hekang develops collagen extraction, collagen / bioceramic composite materials, absorbable calcium Linate ceramics, hyaluronic acid, etc., and cuts into the field of medical materials and medical beauty. At present, it has obtained Taiwan, the United States, the European Union In total, there are more than 27 licenses covering orthopedics, ophthalmology, dentistry, skin callus, plastic surgery And so on. In recent years, hokang company has developed its own brand with its own characteristics by using the professional technology of collagen and hyaluronic acid in the research and development of biomedical materials. In 2009, it was certified by FDA on-the-spot inspection, and in 2012, hecon company cooperated with exactech Inc., a NASDAQ listed company. In 2011, Watsons health care products and facial mask were awarded the best products and best new products of Watsons Health Beauty Awards. In addition, Dr. Xu Lide, chairman of Hekang company, is a senior politician in the former presidential palace. He has successively held various important government positions, including the Minister of finance, the Minister of economy, the chairman of the economic and Construction Commission, the vice president of the Executive Yuan and the senior minister of the presidential palace. Mr. Xu has rich experience in multinational companies. He is still an advisory member of Scotiabank and XL Insurance Co., Ltd. He once served as the president of Taiwan Science Society and won the Eisenhower prize. In 1985, he received a master's degree in public administration from Harvard University, and an honorary doctor of law from Victoria University, Canada, in 1996. Mr. Xu is the founder and chairman of Huanyu Group. Huanyu investment is an early established investment company in Taiwan, and also one of the early and large-scale venture capital in Taiwan.

本文链接: https://brand.waitui.com/69db33b78.html 联系电话:400-606-9608

7×24h 快讯

RoboSense与上汽集团进入规模化量产合作新阶段

36氪获悉,RoboSense速腾聚创正式公布与上汽集团旗下汽车品牌飞凡汽车的定点合作。日前,双方合作的车型之一飞凡F7正式上市交付。这标志着,RoboSense速腾聚创与上汽集团的量产车型定点合作全面进入了规模化量产的新阶段。

2小时前

热门中概股美股盘前多数上涨,京东涨超5%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,京东涨超5%,拟分拆京东产发、京东工业于香港联交所主板独立上市;微博涨超3%,拼多多、蔚来、小鹏汽车、爱奇艺涨超1%,B站涨0.49%,理想汽车涨0.24%,百度跌超2%。

2小时前

贵州茅台:2022年净利润627.16亿元,同比增长19.55%

36氪获悉,贵州茅台发布年报,2022年营业收入1240.99亿元,同比增长16.87%;净利润627.16亿元,同比增长19.55%;基本每股收益49.93元。拟10派259.11元。

2小时前

天齐锂业:2022年净利润241.25亿元,同比增长1060.47%

36氪获悉,天齐锂业发布年报,2022年营业收入404.48亿元,同比增长427.82%;净利润241.24亿元,同比增长1060.47%,拟10派30元。

2小时前

亚朵集团上市后首份成绩单:2022年调整后净利润同比增85.6%至2.59亿元

亚朵集团发布2022年第四季度及全年业绩报告。2022年,亚朵集团实现营收22.63亿元,同比增长5.4%;调整后净利润(非公认会计准则)为2.59亿元,同比增长85.6%。截至2022年12月31日,亚朵集团现金及现金等价物为15.89亿元。报告期内,亚朵新开店191家,仅4家关店,在营酒店数量达932家,房间数达10.8万间,均较上年增长25%;场景零售业务增长迅猛,GMV同比增长42%至3.24亿元。

2小时前

本页详细列出关于芙媄登Formaderm的品牌信息,含品牌所属公司介绍,芙媄登Formaderm所处行业的品牌地位及优势。
咨询